BL-S786 (Ceforanide), a New Parenteral Cephalosporin: In Vitro Studies
- 1 February 1979
- journal article
- research article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 15 (2) , 318-322
- https://doi.org/10.1128/aac.15.2.318
Abstract
BL-S786 (ceforanide) is a new cephalosporin which showed broad-spectrum activity in vitro against 453 clinical isolates. At a concentration of 3.12 μg/ml, it inhibited greater than 75% of isolates of Escherichia coli, Klebsiella spp., Proteus mirabilis, Staphylococcus aureus, Streptococcus pyogenes , and Streptococcus pneumoniae . Essentially no activity was observed against isolates of Serratia marcescens , and only minimal activity was observed against Enterobacter spp. Its activity was directly related to the size of the inoculum. The minimal bactericidal concentrations were similar to the minimal inhibitory concentrations for isolates of all organisms except S. aureus and S. pyogenes . The minimal bactericidal concentrations were considerably higher than the minimal inhibitory concentrations for these organisms.This publication has 6 references indexed in Scilit:
- In Vitro Activity and Beta-Lactamase Stability of BL-S786 Compared with Those of Other CephalosporinsAntimicrobial Agents and Chemotherapy, 1978
- In vitro and in vivo studies with BL-S786, cefoxitin, and cefamandoleAntimicrobial Agents and Chemotherapy, 1978
- BL-S786, a new parenteral cephalosporin. II. in vitro Antimicrobial activity comparison with six related cephalosporins.The Journal of Antibiotics, 1977
- BL-S786, a new parenteral cephalosporin. I. A collaborative in vitro susceptibility comparison to cephalothin against 5,762 clinical bacterial isolates.The Journal of Antibiotics, 1977
- Laboratory Evaluation of BL-S786, a Cephalosporin with Broad-Spectrum Antibacterial ActivityAntimicrobial Agents and Chemotherapy, 1976
- In Vitro Studies of CefamandoleAntimicrobial Agents and Chemotherapy, 1976